Comparison Overview
FUJIFILM Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies
101 J Morris Commons Lane, Morrisville, North Carolina, 27560, US
Last Update: 09/03/2026
For over 30 years, FUJIFILM Diosynth Biotechnology’s mission has been advancing tomorrow’s medicine. As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accele...

Biocon
Hosur Road, Electronics City, Bangalore, Karnataka, IN, 560100
Last Update: 02/04/2026
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a...
Compliance Ranges Comparison

FUJIFILM Diosynth Biotechnologies







Biocon






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for FUJIFILM Diosynth Biotechnologies in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Biocon in 2026.
Incident History - FUJIFILM Diosynth Biotechnologies (X = Date, Y = Severity)
FUJIFILM Diosynth Biotechnologies cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Biocon (X = Date, Y = Severity)
Biocon cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

FUJIFILM Diosynth Biotechnologies

Biocon
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.